María José Terol

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Xosé S. Puente, Rafael Valdés‐Mas, Neus Villamor et al. · Nature · 2015 · 852 citations · Full text

Medicine, Genetics, Molecular Genetics +12

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

María‐Victoria Mateos, JoséM. Hernández, M.B. Gómez Hernández et al. · Blood · 2006 · 389 citations · Full text

Medicine, Hematology, Oncology +15

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Ferran Nadeu, Julio Delgado, Cristina Royo et al. · Blood · 2016 · 333 citations · Full text

Medicine, Molecular Genetics, Oncology +16

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

Bruno Paiva, Norma C. Gutiérrez, Laura Rosiñol et al. · Blood · 2011 · 304 citations · Full text

Medicine, Hematology, Oncology +17